Actively Recruiting
Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
Led by HemoCept Inc. · Updated on 2026-04-13
50
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.
CONDITIONS
Official Title
Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects or their representatives must voluntarily sign the informed consent form before any study procedures.
- Subjects can be any gender and must be 18 years old or older.
- Subjects must be able and willing to provide informed consent and HIPAA authorization.
- Subjects must be able and willing to meet all study requirements.
- Subjects must be scheduled for a diagnostic right heart catheterization procedure (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible).
You will not qualify if you...
- Subjects who are pregnant, breastfeeding, or intend to become pregnant during the study.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Boulder Heart
Boulder, Colorado, United States, 80303
Actively Recruiting
Research Team
K
Katharine Adkins
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here